Testing Featured Articles

  1. ILC Therapeutics’ Interferon Alpha 14 Joins The COVID-19 Fight 5/5/2020

    The Glasgow-based emerging biopharma recently tapped veteran biotech leader Alan Walker as CEO as it moves ahead with two therapeutic candidates, an rIFN alpha14 focused on early-stage COVID-19 infection and a tick-derived Evasin targeting late-stage COVID-19 ARDS patients.

  2. New Podcast: Building Blocks Of The Biopharma Business 4/21/2020

    We just launched the first full episode of the Business of Biotech podcast, a series purpose-built for the leaders of new and emerging biopharma companies. Here’s a recap of the first episode with industry icon Allan Shaw, highlighting the season to come and offering some strategic, straightforward advice for new biopharma leaders.

  3. CDER-ETP: A Resource For Innovative Biopharma Firms 1/15/2020

    The FDA’s Center for Drug Evaluation and Research’s Emerging Technology Program (CDER-ETP), is yet another step toward removing slow-moving bureaucracy and red tape that stands in the way of innovative new technologies that drive drug development. 

  4. Closed System Filling Technology: A New Paradigm 7/7/2016

    “Closed system filling” is a new set of processing controls for a sterile filling process that eliminates potential microbiological contamination from environmental and operator sources.

  5. Staying On Top Of Microbes: Smarter Testing Technology For Labs Of The Future 4/15/2015

    Over the past decade, drug and medical device manufacturers have become leaner and more stream-lined. Given the current market pressures, companies are looking for more ways to improve their bottom-line.

  6. Pilgrim Software's 10th Global Customer Conference Lauds 'Success Through Quality' 4/23/2014

    Pilgrim Software, Inc., a leading provider of cloud and on-premise enterprise quality management solutions, hosted its tenth worldwide customer conference this month.

  7. How Reliable Is The Pharma Equipment You Buy? 8/13/2013

    When it comes to equipment manufacturing in the pharmaceutical industry, it is imperative that a product functions exactly as it was intended. Any misstep caused by faulty equipment could have catastrophic results for the company that produces a drug, but more importantly, for the patient who uses it. The serious consequences that can result from a lack of accurate equipment design and the associated manufacturing processes are why Donald Dobert, president and COO of ATL Pharmaceutical/Medical, created his company’s New Product Development (NPD) Planning Process.

  8. BioOutsource Opens New Facility In Cambridge, Massachusetts 4/23/2013

    BioOutsource Ltd. (“BioOutsource”), a global leader in the biological analysis of biosimilar molecules for the biopharmaceutical industry, today announced the opening of a new facility in Cambridge, Massachusetts, the company’s first in the United States.

  9. Controlled Room Temperature Shipper Ensures Ambient Thermal Protection 3/18/2013

    Sonoco ThermoSafe, a unit of Sonoco and the leading global provider of temperature assurance packaging, has launched the new Certis Silver Universal CRT (controlled room temperature) design-qualified shipper series to ensure ambient thermal protection for pharmaceuticals, biologics, vaccines and other high-value products.

  10. BioReliance Acquires Rights To Big Blue Colonies And Cell Lines From Agilent 3/7/2013

    Sigma-Aldrich Corporation recently announced that BioReliance, the biologics and early development services business under SAFC, has signed an agreement to acquire the colonies required for the Big Blue transgenic rodent mutation (TRM) assay and to obtain a license to its associated trademark from Agilent Technologies.